Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GOLIMUMAB vs INFLIXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GOLIMUMAB vs INFLIXIMAB: Safety Overview

Metric GOLIMUMAB INFLIXIMAB
Total FAERS Reports 69,222 140,189
Deaths Reported 4,866 7,516
Death Rate 7.0% 5.4%
Hospitalizations 15,471 36,324
Average Patient Age 53.0 yrs 43.9 yrs
% Female Patients 79.2% 64.4%
Manufacturer Janssen Biotech, Inc. Organon LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription